OACCW Oaktree Acquisition Corp. III Life Sciences - Warrant
$0.78
Price · May 19, 2026
Fundamentals as of Mar 26, 2026
52W Range
$1–$1
100% of range
Analyst Rating
—
Price Target
—
P/E (TTM)
—
ROE
-109.5%
Net Profit Margin
—
OACCW Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.78
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
-109.5%
Debt/Equity
-0.0
52W Range
$1 – $1
OACCW Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
OACCW
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
OACCW
Peer Median
ROA
3.7%
—
ROE
-109.5%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
OACCW
Peer Median
Debt / Equity
-0.0
—
Current Ratio
1.2
—
Quick Ratio
1.1
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
OACCW
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
OACCW
Peer Median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 5
| Metric | Trend | 2025 |
|---|---|---|
| Operating Income | $-1M | |
| Interest Income | $8M | |
| Other Non-op | $8M | |
| Net Income | $7M | |
| EBITDA | $-1M |
Balance Sheet 13
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $1M | |
| Prepaid Expense | $113.3K | |
| Current Assets | $2M | |
| Total Assets | $203M | |
| Accounts Payable | $502.0K | |
| Short-term Debt | $11.8K | |
| Current Liabilities | $1M | |
| Total Liabilities | $8M | |
| Total Debt | $11.8K | |
| Paid-in Capital | $0 | |
| Retained Earnings | $-7M | |
| Stockholders' Equity | $-7M | |
| Liabilities + Equity | $203M |
Cash Flow 3
| Metric | Trend | 2025 |
|---|---|---|
| Operating Cash Flow | $-422.1K | |
| Investing Cash Flow | $500.0K | |
| Financing Cash Flow | $0 |
Profitability 2
| Metric | Trend | 2025 |
|---|---|---|
| ROA | 3.7% | |
| ROE | -109.5% |
Liquidity & Solvency 3
| Metric | Trend | 2025 |
|---|---|---|
| Current Ratio | 1.2 | |
| Quick Ratio | 1.1 | |
| Debt / Equity | -0.0 |
Valuation (TTM) 1
| Metric | Trend | 2025 |
|---|---|---|
| Net Income TTM | $7M |
Income Statement 5
| Metric | Trend | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Operating Income | $-225.6K | $-269.8K | $-444.8K | |
| Interest Income | $2M | $2M | $2M | |
| Other Non-op | $2M | $2M | · | |
| Net Income | $2M | $2M | $2M | |
| EBITDA | $-225.6K | $-269.8K | $-444.8K |
Balance Sheet 13
| Metric | Trend | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Cash & Equivalents | $1M | $1M | $1M | |
| Prepaid Expense | $152.0K | $175.8K | $201.0K | |
| Current Assets | $1M | $2M | $1M | |
| Total Assets | $201M | $199M | $197M | |
| Accounts Payable | $414.1K | $381.6K | $395.7K | |
| Short-term Debt | $11.8K | $11.8K | $11.8K | |
| Current Liabilities | $1M | $1M | $1M | |
| Total Liabilities | $8M | $8M | $8M | |
| Total Debt | $11.8K | $11.8K | $11.8K | |
| Paid-in Capital | $0 | $0 | $0 | |
| Retained Earnings | $-7M | $-7M | $-7M | |
| Stockholders' Equity | $-7M | $-7M | $-7M | |
| Liabilities + Equity | $201M | $199M | $197M |
Cash Flow 2
| Metric | Trend | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Operating Cash Flow | $-56.5K | $-146.1K | $-75.6K | |
| Investing Cash Flow | $0 | · | · |
Profitability 2
| Metric | Trend | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| ROA | 1.9% | 1.9% | 1.7% | |
| ROE | -58.1% | -57.3% | -50.9% |
Liquidity & Solvency 3
| Metric | Trend | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Current Ratio | 1.2 | 1.4 | 1.4 | |
| Quick Ratio | 1.1 | 1.2 | 1.2 | |
| Debt / Equity | -0.0 | -0.0 | -0.0 |
Valuation (TTM) 1
| Metric | Trend | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Net Income TTM | $5M | · | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Net Income | $7M | — |
Balance Sheet
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Debt / Equity | -0.0 | — |
| Current Ratio | 1.2 | — |
| Quick Ratio | 1.1 | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.